Toward a noninvasive approach to early goal-directed therapy

Chest

Volumn 139, Issue 3, 2011, Pages 726-727

  Coen, Daniele ^a   Vaccaro, Angelica ^a   Cazzaniga, Michela ^a   Cortellaro, Francesca ^a   Monti, Gianpaola ^a   Tombini, Valeria ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; NORADRENALIN; VASOACTIVE AGENT;

CENTRAL VENOUS CATHETER; CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; COLLAPSE; EARLY GOAL DIRECTED THERAPY; ECHOGRAPHY; EMERGENCY WARD; FLUID RESUSCITATION; HUMAN; HYPOTENSION; INFERIOR CAVA VEIN; LACTATE BLOOD LEVEL; LETTER; NON INVASIVE PROCEDURE; OXYGENATION; PRIORITY JOURNAL; SEPSIS; SYSTOLIC BLOOD PRESSURE; TISSUE PERFUSION;

EID: 79952218034     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2632     Document Type: Letter

References (6)

1. Carlbom DJ, Rubenfeld GD. Barriers to implementing protocol-based sepsis resuscitation in the emergency department - results of a national survey. Crit Care Med. 2007;35(11):2525-2532. (Pubitemid 351339012)
2. Schmidt GA. Counterpoint: adherence to early goal-directed therapy: does it really matter? No. Both risks and benefits require further study. Chest. 2010;138(3):480-483.
3. Mikkelsen ME, Gaieski DF, Goyal M, et al. Factors associated with nonadherence to early goal-directed therapy in the ED. Chest. 2010;138(3):551-558.
4. Charron C, Caille V, Jardin F, Vieillard-Baron A. Echocardiographic measurement of fluid responsiveness. Curr Opin Crit Care. 2006;12(3):249-254. (Pubitemid 44365954)
5. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA;Emergency Medicine Shock Research Network (EMShockNet) Investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739-746.
6. Rivers EP. Point: adherence to early goal-directed therapy: does it really matter? Yes. After a decade, the scientific proof speaks for itself. Chest. 2010;138(3):476-480.